High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers

Translational Oncology

Volumn 7, Issue 6, 2014, Pages 732-740

  Taher, Chato ^a   Frisk, Gabriella ^b   Fuentes, Stina ^b   Religa, Piotr ^a   Costa, Helena ^a   Assinger, Alice ^a   Vetvik, Katja Kannisto ^c   Bukholm, Ida R K ^c,d   Yaiw, Koon Chu ^a   Smedby, Karin Ekström ^b   Bäcklund, Magnus ^a   Söderberg Naucle, Cecilia ^a   Rahbar, Afsar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR DIAGNOSIS; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84915825926     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1016/j.tranon.2014.09.008     Document Type: Article

References (34)

1. Gavrilovic IT and Posner JB (2005). Brain metastases: epidemiology and pathophysiology. J Neuro-Oncol 75(1), 5–14[Epub 2005/10/11].
2. Posner JB and Chernik NL (1978). Intracranial metastases from systemic cancer. Adv Neurol 19, 579–592[Epub 1978/01/01].
3. Go PH, Klaassen Z, Meadows MC, and Chamberlain RS (2011). Gastrointestinal cancer and brain metastasis: a rare and ominous sign. Cancer 117(16), 3630–3640[Epub 2011/02/15].
4. Farnell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ, and Suman V (1996). Brain metastases from colorectal carcinoma. The long term survivors. Cancer 78(4), 711–716[Epub 1996/08/15].
5. Smedby KE, Brandt L, Backlund ML, and Blomqvist P (2009). Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 101(11), 1919–1924[Epub 2009/10/15].
6. Noura S, Ohue M, Shingai T, Fujiwara A, Imada S, Sueda T, Yamada T, Fujiwara Y, Ohigashi H, and Yano M, et al (2012). Brain metastasis from colorectal cancer: prognostic factors and survival. J Surg Oncol 106(2), 144–148[Epub 2012/01/31].
7. Shmueli E, Wigler N, and Inbar M (2004). Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. Eur J Cancer 40(3), 379–382[Epub 2004/01/30].
8. Palmieri D, Chambers AF, Felding-Habermann B, Huang S, and Steeg PS (2007). The biology of metastasis to a sanctuary site. Clin Cancer Res 13(6), 1656–1662[Epub 2007/03/17].
9. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, and Byhardt R (1997). Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4), 745–751[Epub 1997/03/01].
10. Fidler IJ, Yano S, Zhang RD, Fujimaki T, and Bucana CD (2002). The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3(1), 53–57[Epub 2002/03/22].
11. Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, and Pagani O, et al (2006). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17(6), 935–944[Epub 2006/04/11].
12. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, and Winer EP (2008). Sites of distant recurrence and clinical outcomes in patients with metastatic triplenegative breast cancer: high incidence of central nervous system metastases. Cancer 113(10), 2638–2645[Epub 2008/10/04].
13. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, and Foekens JA, et al (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459(7249), 1005–1009
14. Epub 2009/05/08].
15. Lorger M, Krueger JS, O'Neal M, Staflin K, and Felding-Habermann B (2009). Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain. Proc Natl Acad Sci U S A 106(26), 10666–10671[Epub 2009/06/23].
16. Lee BC, Lee TH, Avraham S, and Avraham HK (2004). Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2(6), 327–338[Epub 2004/07/06].
17. Nathoo N, Chahlavi A, Barnett GH, and Toms SA (2005). Pathobiology of brain metastases. J Clin Pathol 58(3), 237–242[Epub 2005/03/01].
18. Soderberg-Naucler C (2006). Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259(3), 219–246[Epub 2006/02/16].
19. Soroceanu L and Cobbs CS (2011). Is HCMV a tumor promoter? Virus Res 157 (2), 193–203[Epub 2010/11/03].
20. Melnick M, Sedghizadeh PP, Allen CM, and Jaskoll T (2012). Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: Cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp Mol Pathol 92(1), 118–125[Epub 2011/11/22].
21. Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjornsson B, FuskevAg OM, and Segerstrom L, et al (2011). Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121(10), 4043–4055[Epub 2011/09/29].
22. Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, Pelloski C, and Chiocca EA (2012). Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice. Cancer Res 72(22), 5669–5674[Epub 2012/09/25].
23. Taher C, de Boniface J, Mohammad AA, Religa P, Hartman J, Yaiw KC, Frisell J, Rahbar A, and Soderberg-Naucler C (2013). High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One 8(2), e56795.
24. Wolmer-Solberg N, Baryawno N, Rahbar A, Fuchs D, Odeberg J, Taher C, Wilhelmi V, Milosevic J, Mohammad AA, and Martinsson T, et al (2013). Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? Int J Cancer 133(10), 2351–2361[Epub 2013/05/11].
25. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, and Hengel H, et al (2012). Decoding human cytomegalovirus. Science 338(6110), 1088–1093[Epub 2012/11/28].
26. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, and Liu F (2003). Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100(24), 14223–14228.
27. Geder L, Sanford EJ, Rohner TJ, and Rapp F (1977). Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat Rep 61(2), 139–146.
28. Soderberg-Naucler C, Rahbar A, and Stragliotto G (2013). Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369(10), 985–986[Epub 2013/09/06].
29. Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, and Soderberg-Naucler C (2012). Low levels of Human Cytomegalovirus Infection in Glioblastoma Multiforme associates with patient survival; -a case-control study. Herpesviridae 3(1), 3[Epub 2012/03/20].
30. Dzabic M, Rahbar A, Yaiw KC, Naghibi M, Religa P, Fellstrom B, Larsson E, and Soderberg-Naucler C (2011). Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. Clin Infect Dis 53(10), 969–976[Epub 2011/10/01].
31. Barbieri V, Sanpaolo P, and Genovesi D (2011). Prognostic impact of triple negative phenotype in conservatively treated breast cancer. Breast J 17(4), 377–382[Epub 2011/05/28].
32. Xu Z, Schlesinger D, Toulmin S, Rich T, and Sheehan J (2012). Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. Int J Radiat Oncol Biol Phys 84(3), 612–618[Epub 2012/03/23].
33. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, and Britt WJ (2002). Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12), 3347–3350[Epub 2002/06/18].
34. Stragliotto G, Rahbar A, Solberg NW, Lilja A, Taher C, Orrego A, Bjurman B, Tammik C, Skarman P, and Peredo I, et al (2013). Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 133(5), 1204–1213[Epub 2013/02/14].